在 Elawady 频道的一次联合直播中，一位发言者（Elawady 或其嘉宾 Tamer El-Baz 医生；无法分辨是谁在发言）描述了一位遵循该体系的乳糜泻患者重新吃起含麸质的吐司，并建议在出现症状时暂停，以后再重新引入。
原始表述
ارتاح اتحس فبدا يدخل التوست يعني انا عندي عينه ا سيليك ... اول ما خدت التوست تعبت شويه ... طب استنى وقفيه شويه خلينا نمشي على النظام ورجعيه تاني
按来源为原话. 译文由本项目提供；以阿拉伯语原文为准。
译文
在 Elawady 频道的一次联合直播中，一位发言者（Elawady 或其嘉宾 Tamer El-Baz 医生；无法分辨是谁在发言）描述了一位遵循该体系的乳糜泻患者重新吃起含麸质的吐司，并建议在出现症状时暂停，以后再重新引入。
出处
- 来源状态
- 视频转录文本（本人原话）
- 归属
- Elawady or guest (machine transcript of a joint live stream; speaker not identifiable)
- 视频
- لايف الدكتور تامر الباز ❤️❤️❤️❤️ (打开来源)
- 发布日期
- 2025年7月18日
- 时间戳
- 无（转录文本不含时间信息）
- 归属的不确定性
- Machine transcript of a live stream with Dr. Tamer El-Baz (two speakers separated by '>>'); it cannot be determined which statements are Elawady's. Treat as statements made on Elawady's channel with uncertain speaker.
- 所声称的机制
Coeliac symptoms are due to other foods (eggs etc.), not gluten.
- 所声称的健康影响
Coeliac patients improve and tolerate toast.
- 涉及人群
People with coeliac disease.
- Elawady 设定的地域限制
none found
科学评估
错误 – 该说法与可靠证据相矛盾。
证据确定性: 高 – 进一步研究极不可能改变该评估。
1. 说法是什么？
Coeliac patients on the system can eat toast again.
2. 哪些内容可证实是正确的？
Some people with a coeliac label may have been misdiagnosed; re-evaluation by a gastroenterologist is legitimate. A minority (about 20% in one selected series) of patients diagnosed in childhood show no villous atrophy years after resuming gluten (latency), but some of them relapse later (I-GRN-110).
3. 哪些内容是错误或夸大的？
For confirmed coeliac disease, gluten reintroduction is harmful, regardless of symptoms; symptom improvement after removing other foods does not prove gluten tolerance.
4. 哪些内容仍不明确？
Speaker attribution.
5. 哪些研究支持该说法？
None for symptom-guided reintroduction; I-GRN-110 shows latency in a minority, identifiable only by repeated biopsy.
6. 哪些研究与该说法相矛盾？
I-GRN-02, I-GRN-105 (guidelines: strict lifelong gluten-free diet); I-GRN-107 (50 mg gluten/day damaged the mucosa); I-GRN-108 (14-day challenge halved villus/crypt ratio while symptoms subsided); I-GRN-109 (persistent villous atrophy associated with lymphoma, HR 2.26); I-WHT-04.
7. 对德国和欧洲而言情况如何？
ESsCD: lifelong gluten-free diet with follow-up serology.
8. 关于埃及的已知情况是什么？
Same medical standard.
9. 合理的实际结论是什么？
除非是在医生监督下进行诊断性重新评估，乳糜泻患者不应重新引入麸质。
评估详情
- 证据确定性的依据
The treatment of coeliac disease is a strict gluten-free diet (I-GRN-02); reintroducing gluten causes ongoing intestinal damage even when symptoms are mild. Anecdotal symptom improvement does not show mucosal healing.
- 来源质量
Anecdote in a conversation; speaker attribution uncertain.
- 地区可推广性
Universal.
- 个体例外情况
None.
- 说法的地域范围
- 普遍性（生物学/医学）
- 最近审核
- 2026年10月26日 初步
科学证据详解
已被科学证据否定 – 高质量证据显示情况恰恰相反，或该说法与已确立的生理学知识相矛盾。
研究问题: In people with confirmed coeliac disease, is reintroducing gluten-containing bread (pausing when symptoms appear) safe?
研究问题详解 (PICO)
- 人群
- People with confirmed coeliac disease
- 干预或暴露
- Reintroduction of gluten, guided by symptoms
- 对照
- Strict gluten-free diet
- 地域范围
- universal biology
- 结局指标
- Villous atrophy
- Serology
- Bone density
- Lymphoproliferative malignancy
- Symptoms
研究结果按作者报告呈现。我们的评估见下文。
哪些证据支持该说法？
Most coeliac patients back on gluten have hidden gut damage
A minority (about 20%) of adults diagnosed with coeliac disease in childhood who resumed gluten had no villous atrophy (latency), but 2 of 13 later relapsed.
- 实际结果
- 13/61 latent; 48/61 silent villous atrophy; osteopenia 70% in silent patients.
- 方法学质量
- low (retrospective, selected)
- 相关性
- direct, but mostly contradicts the safety of reintroduction
- 局限
- Selected sample; cannot predict who tolerates gluten.
哪些证据不支持该说法？
Two weeks of gluten damages the gut in coeliac disease even when symptoms fade
Two weeks of >=3 g gluten/day halved the villus/crypt ratio in treated coeliac adults; symptoms returned to baseline by day 28 while antibodies rose.
- 实际结果
- Vh:Cd 2.2 to 1.1 (p<0.001); IEL 32.6 to 51.8.
- 方法学质量
- moderate (small randomised dose study)
- 相关性
- direct
- 局限
- No placebo arm.
Even 50 mg of gluten a day harms the gut in coeliac disease
Even 50 mg gluten/day for 90 days damaged the mucosa.
- 实际结果
- Vh/Cd -20% vs +9% placebo.
- 方法学质量
- moderate (small RCT)
- 相关性
- direct
- 局限
- Small.
European guideline for coeliac disease
Al-Toma A et al.. United European Gastroenterol J 2019 · PMID 31210940 · DOI 10.1177/2050640619844125 指南 / 立场声明全文，含结构化偏倚风险评估Guideline: lifelong strict gluten-free diet (strong recommendation, high-level evidence).
- 实际结果
- Recommendation.
- 方法学质量
- high
- 相关性
- direct
- 局限
- None.
总体证据说明了什么？
基于上述研究的编辑评估——其本身并非研究结果。
哪种观点有更好的证据支持？
Reintroducing gluten in confirmed coeliac disease causes mucosal damage quickly, often without lasting symptoms; symptom-guided "pausing" is unsafe.
为什么有些研究权重更大
Randomised challenge studies with histology and guideline consensus outweigh a retrospective case series of selected patients.
因果关系是否已确立？ 是，已确立 Gluten challenge reproducibly causes villous atrophy in coeliac disease; persistent atrophy is associated with lymphoma (I-GRN-109) and low bone density (I-GRN-110).
仍存在的不确定性
Predictors of long-term latency in a small minority.
合理的结论
Gluten reintroduction should happen only within a supervised diagnostic re-evaluation.
为什么研究结果看起来互相矛盾？
这是否取决于国家？
- 一般生物学效应
- Universal.
- 饮食习惯
- Bread-centred Egyptian diet makes accidental exposure common.
- 食品原产地
- Not relevant.
- 污染物
- Not relevant.
- 本国生产条件
- Not relevant.
- 法律规则
- Not applicable.
- 实际监测数据
- Not applicable.
足以改变结论的地区差异没有可靠数据支持。
统计复核
- Log-symmetry of HR CI – HR 2.26 (1.18-4.34): geometric centre 2.26, consistent. 已重新计算
- Recalculate osteopenia comparison – 1/9 vs 23/33: Fisher exact p=0.0025 (reported p<0.001; still significant, minor discrepancy). 已重新计算
- Relative change of Vh:Cd – 2.2 to 1.1 = 50% reduction in 14 days. 已重新计算
总体证据的确定性（GRADE，简化版）
- 主要结局
- Mucosal damage after gluten reintroduction in coeliac disease
- 起始等级
- 高（随机试验）
- 降级理由
- imprecision (small trials)
- 升级理由
- dose-response/consistency across challenge studies
- 结果
- 高
由单名审查者参照 GRADE 方法进行的简化评估；并非正式的 GRADE 专家组评估。GRADE 评价的是针对某一结局的整体证据，而非单项研究。
已核查的临床指南和官方声明
- ESsCD (European Society for the Study of Coeliac Disease): ESsCD guideline for coeliac disease and other gluten-related disorders (Al-Toma et al., UEG J 2019; study I-GRN-02) (2019) · 原始文献
Diagnostic testing (serology and biopsy) should be performed on a gluten-containing diet; a gluten-free diet should be introduced only when diagnosis is conclusive (strong, high); patients with coeliac disease should adhere to a lifelong gluten-free diet (strong, high); gluten-containing cereals are wheat, barley and rye; maize and oats are naturally gluten-free but can be contaminated; uncontaminated oats are tolerated by most patients; foods labelled gluten-free must contain <=20 ppm (EC 41/2009); NCGS is considered only after coeliac disease and wheat allergy are excluded on a gluten-containing diet; patients advised to eat whole-grain rice, maize, potatoes and vegetables. - American College of Gastroenterology: ACG Guidelines Update: Diagnosis and Management of Celiac Disease (Rubio-Tapia et al., Am J Gastroenterol 2023; I-GRN-105) (2023) · 原始文献
Abstract only (publisher full text blocked): coeliac disease is a permanent immune-mediated response to gluten in wheat, barley and rye; tTG antibodies for screening; biopsy required in most patients; treatment requires strict gluten-free diet and lifelong medical follow-up. - NICE (UK): Coeliac disease: recognition, assessment and management (NG20), Recommendations (2015) · 原始文献
Offer serological testing for unexplained GI symptoms, fatigue, weight loss, unexplained iron/B12/folate deficiency, IBS in adults, type 1 diabetes, first-degree relatives; tests are accurate only on a gluten-containing diet; do not start a gluten-free diet until a specialist confirms the diagnosis; eat gluten in more than one meal daily for at least 6 weeks before testing; gluten-free oats can be included. - Academy of Nutrition and Dietetics: Celiac Disease: An Academy of Nutrition and Dietetics Evidence-Based Nutrition Practice Guideline (McDermid et al., J Acad Nutr Diet 2023) (2023) · 原始文献
Abstract: all individuals with coeliac disease should follow a gluten-free diet (1C, imperative), which may include gluten-free oats in adults (2D, conditional); children should follow a nutritionally adequate gluten-free diet.
检索策略
本次审查的文献检索记录（检索式采用原数据库语法）。
| 数据库 | 日期 | 检索式 | 检索目标 | 命中数 | 纳入数 |
|---|---|---|---|---|---|
| PubMed | 2026年10月26日 | (celiac disease[ti] OR coeliac disease[ti]) AND (latency[tiab] OR tolerance[tiab] OR "gluten reintroduction"[tiab] OR "normal diet"[tiab]) AND (long-term follow-up[tiab]) | 支持性证据 | 4 | |
| PubMed | 2026年10月26日 | Matysiak-Budnik T[au] AND latency[ti] | 支持性证据 | 1 | |
| Europe PMC | 2026年10月26日 | (coeliac OR celiac) AND ("gluten tolerance" OR latency OR "gluten reintroduction" OR "normal diet") AND ("long-term" OR "follow-up") AND (adults OR children) | 支持性证据 | 1929 | |
| PubMed | 2026年10月26日 | safe gluten threshold[ti] celiac | 反对性证据 | 2 | |
| PubMed | 2026年10月26日 | mucosal healing[ti] lymphoproliferative[ti] celiac | 反对性证据 | 1 | |
| Europe PMC | 2026年10月26日 | TITLE:("coeliac" OR "celiac") AND ("gluten challenge") AND (kinetics OR histolog*) AND (PUB_TYPE:"Clinical Trial" OR PUB_TYPE:"Randomized Controlled Trial") | 反对性证据 | 44 | |
| PubMed | 2026年10月26日 | (celiac disease[ti]) AND (guideline[ti] OR guidelines[ti]) AND 2020:2026[dp] | 指南 | 21 |
待解决的问题
None that change the conclusion.
核查深度如何？
8 项相关研究：2 项核查了全文（其中 1 项进行了结构化偏倚风险评估），6 项基于摘要核查，0 项仅核查了文献信息。 尚未进行由两名独立审查者完成的正式评估，也尚未进行独立的人类专家审核。
最近一次科学审核: 2026年10月26日
评定结论的变更历史
- 2026年10月25日 · 第 1 阶段 · 初始评估: 错误 (高)
- 2026年10月26日 · 第 4 阶段（系统证据审查） · 在扩展证据后重新审查；评定结论不变: 错误 (高)
Unchanged; new challenge, threshold and cohort data (I-GRN-107, I-GRN-108, I-GRN-109) directly confirm the harm. The latency literature (I-GRN-110) is acknowledged but does not support symptom-guided reintroduction.
新来源: I-GRN-107 I-GRN-108 I-GRN-109 I-GRN-110 I-GRN-105 I-GRN-106
通俗解释
在频道的一次直播对话中，有人描述乳糜泻患者在遵循该体系后重新吃起了吐司。对于已确诊乳糜泻的人，即使他们只感觉略有不适，麸质也会持续损伤肠道。公认的治疗方法是终身严格无麸质饮食。对诊断有任何疑问，都应由专科医生核查。
与该说法相关的研究
支持该说法的研究 (0)
该组中没有研究。
与该说法相矛盾或限制该说法的研究 (7)
-
European guideline for coeliac disease
Al-Toma A et al.. United European Gastroenterol J 2019 · PMID 31210940 · DOI 10.1177/2050640619844125指南 / 立场声明独立交叉核查全文，含结构化偏倚风险评估★ 关键研究Coeliac disease needs a strict lifelong gluten-free diet; gluten is in wheat, rye and barley (not in uncontaminated rice, maize or oats); non-coeliac gluten sensitivity is recognised after coeliac disease and wheat allergy are excluded.
该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Guideline
- 研究是如何开展的？
Expert consensus guideline with GRADE grading, based on a PubMed literature review
- 实际发现了什么？
GFD is treatment
- 研究结果对日常生活意味着什么？
Coeliac patients must avoid gluten
- 该研究有哪些局限？
Not based on a systematic review; small expert board; no conflict-of-interest statement in available text
- 它对 Elawady 的具体说法说明了什么？
Contradicts denial and reintroduction claims
- 研究结果是否适用于德国和欧洲？
High
- 从该研究中明确不能得出什么结论？
Does not quantify how common NCGS is or whether gluten itself (rather than fructans/ATIs) causes its symptoms
-
How common is coeliac disease?
Singh P et al.. Clin Gastroenterol Hepatol 2018 · PMID 29551598 · DOI 10.1016/j.cgh.2017.06.037Meta分析独立交叉核查已核查摘要★ 关键研究About 1 in 70 have coeliac antibodies and about 1 in 140 biopsy-confirmed disease worldwide.
该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Prevalence
- 研究是如何开展的？
Meta-analysis
- 研究了多少人、动物或样本？
96 studies
- 实际发现了什么？
0.7-1.4%
- 研究结果对日常生活意味着什么？
Coeliac disease is real and not rare
- 该研究有哪些局限？
Heterogeneity
- 它对 Elawady 的具体说法说明了什么？
Contradicts denial of gluten disease
- 研究结果是否适用于德国和欧洲？
High
- 从该研究中明确不能得出什么结论？
Causes of symptoms in non-coeliacs
-
Even 50 mg of gluten a day harms the gut in coeliac disease
Catassi C et al.. Am J Clin Nutr 2007 · PMID 17209192 · DOI 10.1093/ajcn/85.1.160随机对照试验独立交叉核查已核查摘要★ 关键研究In treated coeliac patients, 50 mg gluten daily for 3 months reduced villus height by about 20%; placebo did not.
Small regular gluten doses damage the mucosa.
该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Find a safe trace-gluten level.
- 研究是如何开展的？
Randomised blinded capsule trial.
- 研究了多少人、动物或样本？
49 adults with coeliac disease.
- 实际发现了什么？
50 mg/day damaged villi.
- 观察到的效应有多大？
-20% Vh/Cd vs +9% on placebo.
- 研究结果对日常生活意味着什么？
Strictness matters: small amounts are harmful.
- 该研究有哪些局限？
Small, short.
- 它对 Elawady 的具体说法说明了什么？
Contradicts reintroducing gluten; supports gluten-free standards.
- 研究结果是否适用于德国和欧洲？
Basis of EU limit.
- 从该研究中明确不能得出什么结论？
Does not define risk for each individual.
-
Two weeks of gluten damages the gut in coeliac disease even when symptoms fade
Leffler D et al.. Gut 2013 · PMID 22619366 · DOI 10.1136/gutjnl-2012-302196随机对照试验独立交叉核查已核查摘要★ 关键研究In 20 coeliac adults, 3 g gluten daily for 14 days halved villus height ratio; symptoms rose and then went back to baseline by day 28.
Symptoms are an unreliable guide to intestinal damage.
该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Measure how fast gluten harms coeliac patients.
- 研究是如何开展的？
Gluten challenge with repeated biopsies.
- 研究了多少人、动物或样本？
20 adults.
- 实际发现了什么？
Marked villous damage in 14 days.
- 观察到的效应有多大？
Vh:Cd 2.2 to 1.1.
- 研究结果对日常生活意味着什么？
Feeling fine does not mean the gut is fine.
- 该研究有哪些局限？
Small, no placebo.
- 它对 Elawady 的具体说法说明了什么？
Contradicts symptom-guided gluten reintroduction.
- 研究结果是否适用于德国和欧洲？
High.
- 从该研究中明确不能得出什么结论？
Does not measure long-term complications.
-
Unhealed gut in coeliac disease is linked to more lymphoma
Lebwohl B et al.. Ann Intern Med 2013 · PMID 23922062 · DOI 10.7326/0003-4819-159-3-201308060-00006队列研究独立交叉核查已核查摘要Among 7625 Swedish coeliac patients, those whose gut had not healed had about twice the lymphoma risk of those whose gut had healed.
Ongoing mucosal damage is associated with higher lymphoma risk.
该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Link mucosal healing with lymphoma.
- 研究是如何开展的？
National cohort.
- 研究了多少人、动物或样本？
7625 patients.
- 实际发现了什么？
Persistent damage: higher lymphoma risk.
- 观察到的效应有多大？
HR 2.26.
- 研究结果对日常生活意味着什么？
Healing the gut matters.
- 该研究有哪些局限？
No diet data.
- 它对 Elawady 的具体说法说明了什么？
Contradicts the safety of reintroducing gluten.
- 研究结果是否适用于德国和欧洲？
High.
- 从该研究中明确不能得出什么结论？
Cannot prove gluten exposure caused the cancers.
-
US specialist guideline on coeliac disease (2023)
Rubio-Tapia A et al.. Am J Gastroenterol 2023 · PMID 36602836 · DOI 10.14309/ajg.0000000000002075指南 / 立场声明独立交叉核查已核查摘要★ 关键研究Coeliac disease is a lifelong immune reaction to gluten from wheat, barley and rye; treatment is a strict gluten-free diet with medical follow-up.
Strict GFD and lifelong follow-up are required.
该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Guide diagnosis and treatment.
- 研究是如何开展的？
Expert guideline using GRADE.
- 研究了多少人、动物或样本？
not applicable
- 实际发现了什么？
Antibody test, usually biopsy; strict lifelong gluten-free diet.
- 观察到的效应有多大？
not applicable
- 研究结果对日常生活意味着什么？
People with coeliac disease must avoid gluten strictly.
- 该研究有哪些局限？
Only abstract read.
- 它对 Elawady 的具体说法说明了什么？
Contradicts denial of gluten disorders and gluten reintroduction.
- 研究结果是否适用于德国和欧洲？
Consistent with European guidance.
- 从该研究中明确不能得出什么结论？
Does not address the non-coeliac claims in detail in the abstract.
-
UK guideline: test for coeliac disease before cutting out gluten
National Institute for Health and Care Excellence (NICE). NICE guideline NG20 2015指南 / 立场声明独立交叉核查已核查全文★ 关键研究People with unexplained iron deficiency, IBS-type symptoms and other signs should be tested, and must keep eating gluten until a specialist confirms the diagnosis.
Diagnosis and management need specialist care.
该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Guide recognition and testing.
- 研究是如何开展的？
National guideline.
- 研究了多少人、动物或样本？
not applicable
- 实际发现了什么？
Testing indications; eat gluten for 6 weeks before tests.
- 观察到的效应有多大？
not applicable
- 研究结果对日常生活意味着什么？
Stopping bread before testing can hide coeliac disease.
- 该研究有哪些局限？
Guideline from 2015.
- 它对 Elawady 的具体说法说明了什么？
Contradicts replacing diagnosis by diet change.
- 研究结果是否适用于德国和欧洲？
UK, consistent with EU.
- 从该研究中明确不能得出什么结论？
Does not grade evidence for every recommendation on the page.
该组中没有被标记为关键研究的研究。
结果不一或不明确的研究 (1)
-
Most coeliac patients back on gluten have hidden gut damage
Matysiak-Budnik T et al.. Gut 2007 · PMID 17303598 · DOI 10.1136/gut.2006.100511病例系列 / 病例报告独立交叉核查已核查摘要★ 关键研究Of 61 symptom-free adults back on a normal diet, 48 had villous atrophy and many had bone loss; 13 had no atrophy, but some of those relapsed later.
Some coeliac patients tolerate gluten for years (about 20%), but most symptom-free patients on gluten have villous atrophy and bone loss.
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 低 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Check whether all coeliac patients need lifelong GFD.
- 研究是如何开展的？
Retrospective follow-up with biopsies.
- 研究了多少人、动物或样本？
61 adults diagnosed as children.
- 实际发现了什么？
About 20% latent; 79% silent damage.
- 观察到的效应有多大？
Osteopenia 70% vs 11%.
- 研究结果对日常生活意味着什么？
No symptoms does not mean no harm.
- 该研究有哪些局限？
Small, selected.
- 它对 Elawady 的具体说法说明了什么？
Partly supports tolerance in a minority; overall contradicts symptom-guided reintroduction.
- 研究结果是否适用于德国和欧洲？
High.
- 从该研究中明确不能得出什么结论？
Cannot identify in advance who will tolerate gluten.
该组中没有被标记为关键研究的研究。
地区背景
德国 / 欧盟
ESsCD: lifelong gluten-free diet with follow-up serology.
埃及
Same medical standard.
在我的国家适用什么？
一般科学评估
错误 乳糜泻患者重新引入麸质是不安全的。
以下食品安全领域与该说法相关：
- 农药与农药残留
- 真菌毒素（霉菌毒素）
谷物与大米
选择一个国家，查看针对该国已核查的信息。
局限：法律规则描述的是允许什么，而不是每一种食品实际含有什么。检测数据来自样本，只有结合其方法细节才有意义。
参考文献
- European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders.. Al-Toma A et al.. United European Gastroenterol J 2019 · PMID 31210940 · DOI 10.1177/2050640619844125
- Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis.. Singh P et al.. Clin Gastroenterol Hepatol 2018 · PMID 29551598 · DOI 10.1016/j.cgh.2017.06.037
- A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease.. Catassi C et al.. Am J Clin Nutr 2007 · PMID 17209192 · DOI 10.1093/ajcn/85.1.160
- Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease.. Leffler D et al.. Gut 2013 · PMID 22619366 · DOI 10.1136/gutjnl-2012-302196
- Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: a population-based cohort study.. Lebwohl B et al.. Ann Intern Med 2013 · PMID 23922062 · DOI 10.7326/0003-4819-159-3-201308060-00006
- American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease.. Rubio-Tapia A et al.. Am J Gastroenterol 2023 · PMID 36602836 · DOI 10.14309/ajg.0000000000002075
- Coeliac disease: recognition, assessment and management (NICE guideline NG20) - Recommendations. National Institute for Health and Care Excellence (NICE). NICE guideline NG20 2015
- Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet.. Matysiak-Budnik T et al.. Gut 2007 · PMID 17303598 · DOI 10.1136/gut.2006.100511